Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-08 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
S | Common Stock | D | 29491 | $25.70 - $27.41 | $784,247 |
| 2024-03-08 | Dyne Therapeutics, Inc. | McNeill Jonathan
(Chief Business Officer) |
S | Common Stock | D | 109601 | $25.46 - $27.31 | $2,861,370 |
| 2024-03-08 | Dyne Therapeutics, Inc. | McNeill Jonathan
(Chief Business Officer) |
M | Common Stock | A | 107825 | $5.54 - $5.54 | $597,349 |
| 2024-03-11 | Dyne Therapeutics, Inc. | Farwell Wildon
(Chief Medical Officer) |
S | Common Stock | D | 2615 | $25.58 - $25.70 | $67,081 |
| 2024-03-08 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
S | Common Stock | D | 88924 | $24.99 - $27.33 | $2,329,005 |
| 2024-03-08 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
M | Common Stock | A | 86252 | $5.54 - $5.54 | $477,835 |
| 2024-03-08 | Dyne Therapeutics, Inc. | Brumm Joshua T
(CEO & President) |
S | Common Stock | D | 429730 | $25.30 - $27.38 | $11,125,773 |
| 2024-03-08 | Dyne Therapeutics, Inc. | Brumm Joshua T
(CEO & President) |
M | Common Stock | A | 413343 | $5.54 - $5.54 | $2,289,919 |
| 2024-03-11 | Dyne Therapeutics, Inc. | Beskrovnaya Oxana
(Chief Scientific Officer) |
S | Common Stock | D | 2081 | $25.70 - $25.70 | $53,481 |
| 2024-03-07 | Dyne Therapeutics, Inc. | Brumm Joshua T
(CEO & President) |
S | Common Stock | D | 9086 | $25.85 - $25.85 | $234,873 |
| 2024-03-07 | Dyne Therapeutics, Inc. | Beskrovnaya Oxana
(Chief Scientific Officer) |
S | Common Stock | D | 2373 | $25.85 - $25.85 | $61,342 |
| 2024-03-07 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
S | Common Stock | D | 1591 | $25.85 - $25.85 | $41,127 |
| 2024-03-07 | Dyne Therapeutics, Inc. | Farwell Wildon
(Chief Medical Officer) |
S | Common Stock | D | 9921 | $25.80 - $26.20 | $256,584 |
| 2024-03-07 | Dyne Therapeutics, Inc. | McNeill Jonathan
(Chief Business Officer) |
S | Common Stock | D | 2434 | $25.85 - $25.85 | $62,918 |
| 2024-03-07 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
S | Common Stock | D | 2273 | $25.85 - $25.85 | $58,757 |
| 2024-03-01 | Dyne Therapeutics, Inc. | Rhodes Jason P
(Director) |
S | Common Stock | D | 46534 | $30.05 - $30.05 | $1,398,345 |
| 2024-03-01 | Dyne Therapeutics, Inc. | Atlas Venture Ass...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 46534 | $30.05 - $30.05 | $1,398,345 |
| 2024-02-29 | Dyne Therapeutics, Inc. | Brumm Joshua T
(CEO & President) |
S | Common Stock | D | 100000 | $27.50 - $29.70 | $2,895,517 |
| 2024-02-29 | Dyne Therapeutics, Inc. | Brumm Joshua T
(CEO & President) |
M | Common Stock | A | 100000 | $5.54 - $5.54 | $553,999 |
| 2024-02-29 | Dyne Therapeutics, Inc. | McNeill Jonathan
(Chief Business Officer) |
S | Common Stock | D | 28528 | $27.50 - $29.70 | $811,863 |
| 2024-02-29 | Dyne Therapeutics, Inc. | McNeill Jonathan
(Chief Business Officer) |
M | Common Stock | A | 28528 | $0.73 - $0.73 | $20,824 |
| 2024-02-29 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
S | Common Stock | D | 12740 | $27.50 - $28.65 | $357,295 |
| 2024-02-29 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
M | Common Stock | A | 12740 | $1.03 - $1.03 | $13,121 |
| 2024-02-26 | Dyne Therapeutics, Inc. | Rhodes Jason P
(Director) |
S | Common Stock | D | 807838 | $23.59 - $25.25 | $19,626,893 |
| 2024-02-26 | Dyne Therapeutics, Inc. | Atlas Venture Ass...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 807838 | $23.59 - $25.25 | $19,626,893 |
| 2024-02-21 | Dyne Therapeutics, Inc. | Rhodes Jason P
(Director) |
S | Common Stock | D | 500789 | $22.44 - $23.14 | $11,339,777 |
| 2024-02-21 | Dyne Therapeutics, Inc. | Atlas Venture Ass...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 500789 | $22.44 - $23.14 | $11,339,777 |
| 2024-02-15 | Dyne Therapeutics, Inc. | Rhodes Jason P
(Director) |
S | Common Stock | D | 510152 | $22.71 - $24.45 | $11,867,289 |
| 2024-02-15 | Dyne Therapeutics, Inc. | Atlas Venture Ass...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 510152 | $22.71 - $24.45 | $11,867,289 |
| 2024-02-12 | Dyne Therapeutics, Inc. | Farwell Wildon
(Chief Medical Officer) |
S | Common Stock | D | 5493 | $25.07 - $25.07 | $137,709 |
| 2024-01-29 | Dyne Therapeutics, Inc. | Brumm Joshua T
(CEO & President) |
G | Common Stock | D | 21500 | $0.00 - $0.00 | $0 |
| 2024-01-26 | Dyne Therapeutics, Inc. | Farwell Wildon
(Chief Medical Officer) |
S | Common Stock | D | 100 | $25.00 - $25.00 | $2,500 |
| 2024-01-26 | Dyne Therapeutics, Inc. | McNeill Jonathan
(Chief Business Officer) |
S | Common Stock | D | 20000 | $24.52 - $25.14 | $490,509 |
| 2024-01-26 | Dyne Therapeutics, Inc. | McNeill Jonathan
(Chief Business Officer) |
M | Common Stock | A | 20000 | $0.73 - $0.73 | $14,600 |
| 2024-01-26 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
S | Common Stock | D | 13000 | $24.34 - $24.34 | $316,420 |
| 2024-01-26 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
M | Common Stock | A | 13000 | $1.03 - $1.03 | $13,390 |
| 2024-01-09 | Dyne Therapeutics, Inc. | Kersten Dirk
(Director) |
P | Common Stock | A | 1714285 | $17.50 - $17.50 | $29,999,987 |
| 2024-01-03 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
S | Common Stock | D | 13000 | $18.81 - $18.81 | $244,529 |
| 2024-01-03 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(SVP, Head of Finance & Admin.) |
M | Common Stock | A | 13000 | $1.03 - $1.03 | $13,390 |
| 2023-12-14 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(See Remarks) |
S | Common Stock | D | 2376 | $12.02 - $12.02 | $28,559 |
| 2023-12-11 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
S | Common Stock | D | 1616 | $10.72 - $10.72 | $17,323 |
| 2023-12-04 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(See Remarks) |
S | Common Stock | D | 2553 | $12.01 - $12.01 | $30,660 |
| 2023-11-15 | Dyne Therapeutics, Inc. | Scalzo Richard Wi...
(See Remarks) |
A | Common Stock | A | 89742 | $0.00 - $0.00 | $0 |
| 2023-11-15 | Dyne Therapeutics, Inc. | McNeill Jonathan
(Chief Business Officer) |
A | Common Stock | A | 96158 | $0.00 - $0.00 | $0 |
| 2023-11-02 | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI
(Chief Operating Officer) |
S | Common Stock | D | 9939 | $7.40 - $7.40 | $73,548 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |